BG108571A - Crystalline composition containing escitalopram - Google Patents

Crystalline composition containing escitalopram

Info

Publication number: BG108571A
Authority: BG; Bulgaria
Prior art keywords: composition containing; crystalline composition; containing escitalopram; escitalopram; crystalline particles
Prior art date: 2001-07-31

Application number

BG108571A

Other languages

Bulgarian (bg)

English (en)

Inventor

Troels Christensen

Ken Liljegren

Michiel Elema

Lene Andresen

Shashank Mahashabde

Sebastian Assenza

Original Assignee

H.Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-31

Filing date

2004-02-09

Publication date

2005-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160647&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG108571(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-02-09 Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S

2005-02-28 Publication of BG108571A publication Critical patent/BG108571A/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Cephalosporin Compounds (AREA)

BG108571A 2001-07-31 2004-02-09 Crystalline composition containing escitalopram BG108571A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DKPA200101164		2001-07-31

Publications (1)

Publication Number	Publication Date
BG108571A true BG108571A (en)	2005-02-28

Family

ID=8160647

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108571A BG108571A (en)	2001-07-31	2004-02-09	Crystalline composition containing escitalopram

Country Status (40)

Country	Link
US (3)	US6916941B2 (fr)
EP (2)	EP1414435B1 (fr)
JP (4)	JP2005525993A (fr)
KR (1)	KR20040028947A (fr)
CN (2)	CN1660074A (fr)
AR (1)	AR034898A1 (fr)
AT (2)	ATE352546T1 (fr)
AU (1)	AU2002355624B2 (fr)
BG (1)	BG108571A (fr)
BR (1)	BR0206164A (fr)
CA (1)	CA2451915C (fr)
CO (1)	CO5560540A2 (fr)
CY (1)	CY1106413T1 (fr)
DE (2)	DE60217932T2 (fr)
DK (2)	DK1522539T3 (fr)
EA (1)	EA006213B1 (fr)
EG (1)	EG24206A (fr)
ES (2)	ES2233842T3 (fr)
HK (1)	HK1070000A1 (fr)
HR (2)	HRP20031073A2 (fr)
HU (1)	HUP0401946A2 (fr)
IL (2)	IL159326A0 (fr)
IS (1)	IS7077A (fr)
MA (1)	MA27349A1 (fr)
ME (1)	MEP2108A (fr)
MX (1)	MXPA04000849A (fr)
MY (1)	MY126238A (fr)
NO (1)	NO328346B1 (fr)
NZ (1)	NZ530157A (fr)
PE (1)	PE20030304A1 (fr)
PL (1)	PL366995A1 (fr)
PT (2)	PT1522539E (fr)
RS (1)	RS8304A (fr)
SI (1)	SI1414435T1 (fr)
TN (1)	TNSN04021A1 (fr)
TR (1)	TR200400189T2 (fr)
UA (1)	UA79930C2 (fr)
UY (1)	UY27404A1 (fr)
WO (1)	WO2003011278A1 (fr)
ZA (1)	ZA200309684B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA004033B1 (ru)	1999-04-14	2003-12-25	Х.Лундбекк А/С	Способ получения циталопрама
US20030109577A1 (en) *	2000-10-27	2003-06-12	Ken Liljegren	Pharmaceutical composition containing citalopram
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
HUP0401946A2 (hu)	2001-07-31	2005-01-28	H. Lundbeck A/S	Escitalopramot tartalmazó kristályos gyógyszerkészítmény
AR040970A1 (es)	2002-08-12	2005-04-27	Lundbeck & Co As H	Metodo para la separacion de intermediarios que pueden ser utilizados para la preparacion de escitalopram
US20050154052A1 (en) *	2003-03-24	2005-07-14	Hetero Drugs Limited	Novel crystalline forms of (s)-citalopram oxalate
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
TWI339651B (en) *	2004-02-12	2011-04-01	Lundbeck & Co As H	Method for the separation of intermediates which may be used for the preparation of escitalopram
CA2558198A1 (fr) *	2004-03-05	2005-09-15	H. Lundbeck A/S	Composition cristalline contenant de l'oxalate d'escitalopram
US20050196453A1 (en) *	2004-03-05	2005-09-08	H. Lundbeck A/S	Crystalline composition containing escitalopram
WO2006123243A2 (fr) *	2005-05-20	2006-11-23	Aurobindo Pharma Limited	Formes galeniques pharmaceutiques d'un antidepresseur
TWI358407B (en) *	2005-06-22	2012-02-21	Lundbeck & Co As H	Crystalline base of escitalopram and orodispersibl
US7834201B2 (en)	2005-06-22	2010-11-16	H. Lundbeck A/S	Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
ES2308750T3 (es) *	2005-08-29	2008-12-01	Teva Pharmaceutical Industries Ltd	Tadalafil en particulas solidas que presenta una distribucion de particulas bimodal.
WO2007053796A2 (fr)	2005-10-14	2007-05-10	Forest Laboratories, Inc.	Procedes de traitement de troubles du systeme nerveux central avec une combinaison de faible dose d'escitaloprame et de bupropion
US20070134322A1 (en) *	2005-12-14	2007-06-14	Forest Laboratories, Inc.	Modified and pulsatile release pharmaceutical formulations of escitalopram
GB0601286D0 (en)	2006-01-23	2006-03-01	Sandoz Ag	Asymmetric synthesis
WO2008059514A2 (fr) *	2006-07-31	2008-05-22	Cadila Healthcare Limited	Procédé de préparation d'escitalopram
CA2672925A1 (fr)	2006-10-20	2008-04-24	Ratiopharm Gmbh	Escitalopram et composition pharmaceutique solide comprenant cette structure
US20090048336A1 (en) *	2007-08-17	2009-02-19	Naveen Kumar Kolla	Escitalopram oxalate powders
EP2291177A2 (fr) *	2008-05-05	2011-03-09	Farmaprojects, S.A.	Compositions pharmaceutiques stables et procédés de préparation desdites compositions adaptés à l échelle industrielle
EP2116231A1 (fr)	2008-05-07	2009-11-11	Hexal Ag	Granulé comprenant de l'oxalate d'escitalopram
GR20080100696A (el)	2008-10-23	2010-05-13	Genepharm �.�.	Φαρμακοτεχνικη μορφη με βελτιωμενη γευση του φαρμακευτικα αποδεκτου αλατος εσιταλοπραμης
ITMI20120448A1 (it) *	2012-01-30	2013-07-31	Carthesia Sas	Composizione liofilizzata di escitalopram ossalato per somministrazione sublinguale
ITMI20120106A1 (it) *	2012-01-30	2013-07-31	Carthesia S A S	Pastiglie liofilizzate di escitalopram ossalato per somministrazione sublinguale
CN106389374A (zh) *	2015-08-03	2017-02-15	深圳信立泰药业股份有限公司	一种含有lcz696的药物组合物及其制备方法
JP2018016569A (ja) *	2016-07-26	2018-02-01	株式会社トクヤマ	（１ｓ）−１−［３−（ジメチルアミノ）プロピル］−１−（４−フルオロフェニル）−１，３−ジヒドロイソベンゾフラン−５−カルボニトリル蓚酸塩の製造方法
JP6423133B1 (ja) *	2017-04-10	2018-11-14	東和薬品株式会社	エスシタロプラム医薬組成物
CN107441052A (zh) *	2017-06-21	2017-12-08	山东京卫制药有限公司	一种含有草酸艾司西酞普兰的片剂及其制备方法
KR102089737B1 (ko) *	2017-11-01	2020-03-16	한국화학연구원	에씨탈로프람을 함유한 미립구형 서방출 주사제 및 그의 제조방법
JP7453859B2 (ja)	2020-06-22	2024-03-21	東和薬品株式会社	エスシタロプラム錠剤

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1143702A (fr) *	1965-03-18
GB1358915A (en)	1971-09-13	1974-07-03	Merck & Co Inc	Directly compressed tablet and composition therefor
GB1526331A (en) *	1976-01-14	1978-09-27	Kefalas As	Phthalanes
GB8419963D0 (en) *	1984-08-06	1984-09-12	Lundbeck & Co As H	Intermediate compound and method
DE3688827T2 (de) *	1985-10-25	1994-03-31	Beecham Group Plc	Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8814057D0 (en) *	1988-06-14	1988-07-20	Lundbeck & Co As H	New enantiomers & their isolation
US5296507A (en) *	1990-09-06	1994-03-22	H.Lundbeck A/S	Treatment of cerbrovascular disorders
GB9325644D0 (en)	1993-12-15	1994-02-16	Smithkline Beecham Plc	Novel formulation
US5683720A (en) *	1994-10-28	1997-11-04	Fuisz Technologies Ltd.	Liquiflash particles and method of making same
EP0714663A3 (fr)	1994-11-28	1997-01-15	Lilly Co Eli	Potentialisation d'un médicament par un antagoniste du récepteur sérotonine 1A
AU5966196A (en)	1995-06-08	1997-01-09	Eli Lilly And Company	Methods of treating cold and allergic rhinitis
CN1206207C (zh)	1997-07-08	2005-06-15	H.隆德贝克有限公司	氰酞氟苯胺的制备方法
GB9714841D0 (en)	1997-07-14	1997-09-17	Smithkline Beecham Plc	Treatment method
US5980941A (en) *	1997-08-20	1999-11-09	Fuisz Technologies Ltd.	Self-binding shearform compositions
US5869098A (en) *	1997-08-20	1999-02-09	Fuisz Technologies Ltd.	Fast-dissolving comestible units formed under high-speed/high-pressure conditions
US5840334A (en) *	1997-08-20	1998-11-24	Fuisz Technologies Ltd.	Self-binding shearform compositions
UA62985C2 (en)	1997-11-10	2004-01-15	Lunnbeck As H	A method for the preparation of citalopram
BR9714925A (pt)	1997-11-11	2003-07-22	Lundbeck & Co As H	Método para preparação de citalopran, composto e composição farmacêutica antidepressiva
JP3892667B2 (ja)	1998-10-20	2007-03-14	ハー・ルンドベック・アクチエゼルスカベット	シタロプラムの製造方法
TWI230618B (en) *	1998-12-15	2005-04-11	Gilead Sciences Inc	Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
EA004033B1 (ru)	1999-04-14	2003-12-25	Х.Лундбекк А/С	Способ получения циталопрама
ITMI991579A1 (it)	1999-06-25	2001-01-15	Lundbeck & Co As H	Metodo per la preparazione di citalopram
AR021155A1 (es)	1999-07-08	2002-06-12	Lundbeck & Co As H	Tratamiento de desordenes neuroticos
AU7405000A (en) *	1999-09-28	2001-04-30	H. Lundbeck A/S	Melt granulated composition and modified release dosage form prepared from said composition
GB2357762B (en)	2000-03-13	2002-01-30	Lundbeck & Co As H	Crystalline base of citalopram
US6977306B2 (en) *	2000-05-02	2005-12-20	Sumitomo Chemical Company, Limited	Citalopram hydrobromide crystal and method for crystallization thereof
US20030232881A1 (en) *	2000-10-27	2003-12-18	H. Lundbeck A/S	Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
HUP0401946A2 (hu) *	2001-07-31	2005-01-28	H. Lundbeck A/S	Escitalopramot tartalmazó kristályos gyógyszerkészítmény

2002
- 2002-07-25 HU HU0401946A patent/HUP0401946A2/hu unknown
- 2002-07-25 EA EA200400243A patent/EA006213B1/ru not_active IP Right Cessation
- 2002-07-25 DE DE60217932T patent/DE60217932T2/de not_active Revoked
- 2002-07-25 DE DE60202615T patent/DE60202615T2/de not_active Revoked
- 2002-07-25 EP EP02750846A patent/EP1414435B1/fr not_active Revoked
- 2002-07-25 AT AT04029282T patent/ATE352546T1/de not_active IP Right Cessation
- 2002-07-25 BR BR0206164-3A patent/BR0206164A/pt not_active Application Discontinuation
- 2002-07-25 RS YU8304A patent/RS8304A/sr unknown
- 2002-07-25 CN CN2004100941660A patent/CN1660074A/zh active Pending
- 2002-07-25 ZA ZA200309684A patent/ZA200309684B/xx unknown
- 2002-07-25 ME MEP-21/08A patent/MEP2108A/xx unknown
- 2002-07-25 PT PT04029282T patent/PT1522539E/pt unknown
- 2002-07-25 DK DK04029282T patent/DK1522539T3/da active
- 2002-07-25 JP JP2003516508A patent/JP2005525993A/ja active Pending
- 2002-07-25 IL IL15932602A patent/IL159326A0/xx unknown
- 2002-07-25 AR ARP020102808A patent/AR034898A1/es unknown
- 2002-07-25 AT AT02750846T patent/ATE286730T1/de active
- 2002-07-25 SI SI200230091T patent/SI1414435T1/xx unknown
- 2002-07-25 KR KR10-2004-7001140A patent/KR20040028947A/ko not_active Application Discontinuation
- 2002-07-25 PT PT02750846T patent/PT1414435E/pt unknown
- 2002-07-25 NZ NZ530157A patent/NZ530157A/en not_active IP Right Cessation
- 2002-07-25 MX MXPA04000849A patent/MXPA04000849A/es active IP Right Grant
- 2002-07-25 TR TR2004/00189T patent/TR200400189T2/xx unknown
- 2002-07-25 CN CNB028150317A patent/CN1311819C/zh not_active Expired - Lifetime
- 2002-07-25 DK DK02750846T patent/DK1414435T3/da active
- 2002-07-25 EP EP04029282A patent/EP1522539B1/fr not_active Revoked
- 2002-07-25 PL PL02366995A patent/PL366995A1/xx unknown
- 2002-07-25 UA UA20031212659A patent/UA79930C2/uk unknown
- 2002-07-25 AU AU2002355624A patent/AU2002355624B2/en not_active Ceased
- 2002-07-25 ES ES02750846T patent/ES2233842T3/es not_active Expired - Lifetime
- 2002-07-25 CA CA2451915A patent/CA2451915C/fr not_active Expired - Fee Related
- 2002-07-25 WO PCT/DK2002/000513 patent/WO2003011278A1/fr active Application Filing
- 2002-07-25 ES ES04029282T patent/ES2280892T3/es not_active Expired - Lifetime
- 2002-07-26 PE PE2002000675A patent/PE20030304A1/es not_active Application Discontinuation
- 2002-07-28 EG EG2002070849A patent/EG24206A/xx active
- 2002-07-30 UY UY27404A patent/UY27404A1/es not_active Application Discontinuation
- 2002-07-30 MY MYPI20022871A patent/MY126238A/en unknown
2003
- 2003-03-31 US US10/403,453 patent/US6916941B2/en not_active Expired - Lifetime
- 2003-12-11 IL IL159326A patent/IL159326A/en unknown
- 2003-12-15 IS IS7077A patent/IS7077A/is unknown
- 2003-12-23 HR HR20031073A patent/HRP20031073A2/xx not_active Application Discontinuation
2004
- 2004-01-27 TN TNP2004000021A patent/TNSN04021A1/en unknown
- 2004-01-28 NO NO20040380A patent/NO328346B1/no not_active IP Right Cessation
- 2004-02-04 MA MA27512A patent/MA27349A1/fr unknown
- 2004-02-09 BG BG108571A patent/BG108571A/xx unknown
- 2004-02-25 CO CO04016758A patent/CO5560540A2/es not_active Application Discontinuation
2005
- 2005-02-07 US US11/053,641 patent/US7420069B2/en not_active Expired - Lifetime
- 2005-04-04 HK HK05102804A patent/HK1070000A1/xx not_active IP Right Cessation
2007
- 2007-03-23 CY CY20071100411T patent/CY1106413T1/el unknown
2008
- 2008-08-22 US US12/196,812 patent/US20080305164A1/en not_active Abandoned
- 2008-08-22 HR HR20080410A patent/HRPK20080410B3/xx not_active IP Right Cessation
2010
- 2010-03-16 JP JP2010059368A patent/JP4971477B2/ja not_active Expired - Lifetime
2011
- 2011-05-30 JP JP2011120483A patent/JP5192568B2/ja not_active Expired - Lifetime
2012
- 2012-07-26 JP JP2012166170A patent/JP5719811B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DK1522539T3 (da)	2007-05-07
DK1414435T3 (da)	2005-05-09
MY126238A (en)	2006-09-29
JP2010150283A (ja)	2010-07-08
CN1536997A (zh)	2004-10-13
UA79930C2 (en)	2007-08-10
ATE286730T1 (de)	2005-01-15
SI1414435T1 (en)	2005-06-30
US20050147674A1 (en)	2005-07-07
CN1660074A (zh)	2005-08-31
HRP20031073A2 (en)	2004-04-30
US20080305164A1 (en)	2008-12-11
JP2005525993A (ja)	2005-09-02
CO5560540A2 (es)	2005-09-30
CY1106413T1 (el)	2011-10-12
ZA200309684B (en)	2004-12-22
NO328346B1 (no)	2010-02-01
DE60217932T2 (de)	2007-08-30
RS8304A (en)	2006-12-15
NO20040380L (no)	2004-01-28
EA200400243A1 (ru)	2004-06-24
NZ530157A (en)	2007-06-29
EP1414435B1 (fr)	2005-01-12
EP1522539A1 (fr)	2005-04-13
EG24206A (en)	2008-10-21
MA27349A1 (fr)	2005-06-01
WO2003011278A1 (fr)	2003-02-13
EP1522539B1 (fr)	2007-01-24
JP5192568B2 (ja)	2013-05-08
JP2012211186A (ja)	2012-11-01
TR200400189T2 (tr)	2004-12-21
UY27404A1 (es)	2003-02-28
ES2233842T3 (es)	2005-06-16
CA2451915C (fr)	2010-09-21
IS7077A (is)	2003-12-15
KR20040028947A (ko)	2004-04-03
BR0206164A (pt)	2003-10-28
PT1414435E (pt)	2005-05-31
HK1070000A1 (en)	2005-06-10
EP1414435A1 (fr)	2004-05-06
JP4971477B2 (ja)	2012-07-11
HRPK20080410B3 (en)	2009-09-30
DE60202615T2 (de)	2006-01-12
ATE352546T1 (de)	2007-02-15
EA006213B1 (ru)	2005-10-27
IL159326A (en)	2010-05-31
US7420069B2 (en)	2008-09-02
DE60217932D1 (de)	2007-03-15
MEP2108A (xx)	2010-02-10
TNSN04021A1 (en)	2006-06-01
US6916941B2 (en)	2005-07-12
DE60202615D1 (de)	2005-02-17
CN1311819C (zh)	2007-04-25
PE20030304A1 (es)	2003-03-27
ES2280892T3 (es)	2007-09-16
AU2002355624B2 (en)	2006-02-02
HRP20080410A2 (en)	2008-10-31
HUP0401946A2 (hu)	2005-01-28
IL159326A0 (en)	2004-06-01
CA2451915A1 (fr)	2003-02-13
AR034898A1 (es)	2004-03-24
JP2011195591A (ja)	2011-10-06
MXPA04000849A (es)	2004-05-14
JP5719811B2 (ja)	2015-05-20
US20030212128A1 (en)	2003-11-13
PT1522539E (pt)	2007-03-30
PL366995A1 (en)	2005-02-07

Publication	Publication Date	Title
BG108571A (en)	2005-02-28	Crystalline composition containing escitalopram
HUP9801615A2 (hu)	1999-07-28	Szimetikon/vízmentes kalcium-foszfát-kompozíciók
AU675036B2 (en)	1997-01-16	Process for the preparation of organophilic metal oxide particles
AU4175296A (en)	1996-06-17	Composite material containing aerogel, process for manufacturing said material and the use thereof
CA2487054A1 (fr)	2004-05-21	Preparations de fibrate nanoparticulaire
AU2002363875A1 (en)	2003-07-09	Nanoparticulate preparation
CA2253797A1 (fr)	1998-09-11	Composition pour pierre artificielle a luminescence nocturne ou fluorescente
CA2430318A1 (fr)	2002-06-06	Formulation pulverulente et son procede de production
CA2390338A1 (fr)	2001-06-07	Compositions de liant pour lier des materiaux particulaires
ATE407560T1 (de)	2008-09-15	Granuliertes brotverbesserungmittel zur herstellung von teigwaren
AU2002363415A1 (en)	2003-05-19	Tightly agglomerated non-oxide particles and method for producing the same
ZA952771B (en)	1996-10-04	Novel compound
DE69907119D1 (de)	2003-05-28	Pulverisierte-Sorbitol und ihr Verfahren zur Herstellung
CA2338856A1 (fr)	2000-03-16	Substance antisudorifique et compositions la contenant
AP2000001837A0 (en)	2000-06-30	Pharmaceutical compositions containing micronized bicyclic drugs.
IL161617A0 (en)	2004-09-27	Desmethyl and didesmethyl metabolites of citalopram, methods for the preparation thereof and pharmaceutical compositions containing the same
AU2002219180A1 (en)	2002-06-18	Clay composition
UA74388C2 (uk)	2005-12-15	Фармацевтичні композиції тизоксаніду і нітазоксаніду
IT1269508B (it)	1997-04-01	Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle
AU2002246211A1 (en)	2002-09-24	Solid composition containing at least 75 % by weight of solid particles and at least one non-volatile liquid oil
MY125453A (en)	2006-08-30	Silica filler and method for its production
AU2002246212A1 (en)	2002-09-24	Solid composition containing colouring material and at least 75 % by weight of solid particles
AU7773900A (en)	2001-04-10	Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds
AU641411B2 (en)	1993-09-23	Nitrofurantoin crystals
AU2002251138A1 (en)	2002-09-24	Solid composition containing solid particles comprising at least one part fibres